• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, October 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Biomedical researcher gets $1.9 million to study influenza vaccines and cross protective immunity

Bioengineer by Bioengineer
July 31, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Georgia State University

ATLANTA–Dr. Sang-Moo Kang, professor in the Institute for Biomedical Sciences at Georgia State University, has renewed a four-year, $1.9 million federal grant to develop influenza vaccines that offer enhanced protection against a broad range of influenza virus strains.

This is the second grant renewal from the National Institute for Allergy and Infectious Diseases of the National Institutes of Health. The project will explore novel approaches to improve the cross protective properties of licensed seasonal influenza vaccines, with results expected to be applicable to the clinic and have a significant impact on public health.

Dr. Richard Plemper, a professor in the Institute for Biomedical Sciences, will be a co-investigator for the research project.

Influenza, a contagious respiratory illness caused by influenza viruses, can cause mild to severe illness and even lead to death. Influenza vaccines, such as inactivated split virus vaccines and live attenuated influenza virus vaccines, that are based on immunity to the hemagglutinin (HA) hypervariable protein, do not provide effective cross protection against new influenza virus strains that develop through changes in the virus' genes as it replicates over time. Developing a novel vaccine that improves the efficacy and extent of cross protection is a high priority.

"With this project, we've proposed groundbreaking approaches to increase the capacity of current influenza vaccine platforms to give cross protection against new influenza virus strains," Kang said. "We will achieve this by incorporating M2e epitopes, which are found among all influenza strains, into HA and engineering a M2e-HA molecule."

This project has three aims. First, the researchers will test the hypothesis that recombinant seasonal inactivated split virus vaccines and live attenuated influenza virus vaccines with M2e-HA molecules will enhance the efficacy of cross protection by inducing immunity to M2e and HA.

Secondly, the research team will study recombinant influenza virus vaccines and investigate the role of cellular and humoral immune mechanisms in cross protection in mice. Lastly, the researchers will validate the efficacy of cross protection by recombinant influenza virus vaccines in ferrets, the most relevant small-animal model for the assessment of influenza vaccines, in collaboration with a team led by Dr. Ian York at the Centers for Disease Control and Prevention in Atlanta.

An abstract of the grant, 2R01AI093772-07A1, is available at NIH's Project RePORTer website.

For more information about the Institute for Biomedical Sciences, visit http://biomedical.gsu.edu.

###

Media Contact

LaTina Emerson
[email protected]
404-413-1353
@GSU_News

http://www.gsu.edu

Original Source

http://news.gsu.edu/2017/07/31/biomedical-study-flu-vaccines/

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Uncovering Hybridization in Lycium Species via Genomics

October 28, 2025
Babesia Bigemina Prevalence Linked to Punjab Bovine Risks

Babesia Bigemina Prevalence Linked to Punjab Bovine Risks

October 28, 2025

Amebiasis Impairs Male Fertility via SPATA6 Methylation

October 28, 2025

Mount Sinai Receives $4.5M BD2 Grant to Propel Bipolar Disorder Biology Research

October 28, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1288 shares
    Share 514 Tweet 322
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    310 shares
    Share 124 Tweet 78
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    198 shares
    Share 79 Tweet 50
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    135 shares
    Share 54 Tweet 34

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Biofertilizers: Future of Sustainable Agriculture Unveiled

Advancing Exosome Therapy for Premature Ovarian Insufficiency

Uncovering Hybridization in Lycium Species via Genomics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 67 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.